These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15017387)

  • 1. E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies.
    Fukuyo Y; Mogi K; Tsunematsu Y; Nakajima T
    Cell Death Differ; 2004 Jul; 11(7):747-59. PubMed ID: 15017387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
    Dahle Ø; Bakke O; Gabrielsen OS
    Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear organization of PML bodies in leukaemic and multiple myeloma cells.
    Krejcí J; Harnicarová A; Kůrová J; Uhlírová R; Kozubek S; Legartová S; Hájek R; Bártová E
    Leuk Res; 2008 Dec; 32(12):1866-77. PubMed ID: 18534676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies.
    Zong RT; Das C; Tucker PW
    EMBO J; 2000 Aug; 19(15):4123-33. PubMed ID: 10921892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress.
    Dellaire G; Bazett-Jones DP
    Bioessays; 2004 Sep; 26(9):963-77. PubMed ID: 15351967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
    Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
    J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin.
    Chalkiadaki A; Talianidis I
    Mol Cell Biol; 2005 Jun; 25(12):5095-105. PubMed ID: 15923626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
    Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
    Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32.
    Sunayama J; Ando Y; Itoh N; Tomiyama A; Sakurada K; Sugiyama A; Kang D; Tashiro F; Gotoh Y; Kuchino Y; Kitanaka C
    Cell Death Differ; 2004 Jul; 11(7):771-81. PubMed ID: 15031724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional proteomic analysis of promyelocytic leukaemia nuclear bodies in irradiation-induced MCF-7 cells.
    Liu J; Song Y; Tian B; Qian J; Dong Y; Liu J; Liu B; Sun Z
    J Biochem; 2010 Dec; 148(6):659-67. PubMed ID: 20823370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1.
    Fukuyo Y; Horikoshi N; Ishov AM; Silverstein SJ; Nakajima T
    J Virol; 2011 Apr; 85(7):3356-66. PubMed ID: 21248039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimer formation of the myeloid zinc finger 1 SCAN domain and association with promyelocytic leukemia nuclear bodies.
    Noll L; Peterson FC; Hayes PL; Volkman BF; Sander T
    Leuk Res; 2008 Oct; 32(10):1582-92. PubMed ID: 18472161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease.
    Zimber A; Nguyen QD; Gespach C
    Cell Signal; 2004 Oct; 16(10):1085-104. PubMed ID: 15240004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.
    Wang WH; Kuo CW; Chang LK; Hung CC; Chang TH; Liu ST
    J Virol; 2015 Sep; 89(17):8922-31. PubMed ID: 26085145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML.
    Weisshaar SR; Keusekotten K; Krause A; Horst C; Springer HM; Göttsche K; Dohmen RJ; Praefcke GJ
    FEBS Lett; 2008 Sep; 582(21-22):3174-8. PubMed ID: 18708055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA viruses and viral proteins that interact with PML nuclear bodies.
    Everett RD
    Oncogene; 2001 Oct; 20(49):7266-73. PubMed ID: 11704855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
    Zhou D; Chen B; Ye JJ; Chen S
    Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-regulated cytoskeleton-associated protein Arc/Arg3.1 binds to spectrin and associates with nuclear promyelocytic leukemia (PML) bodies.
    Bloomer WA; VanDongen HM; VanDongen AM
    Brain Res; 2007 Jun; 1153():20-33. PubMed ID: 17466953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.